The potential to protect and provide hope for immunocompromised patients
With a goal of supporting those who've been there all along
Working to potentially expand treatment options for healthcare professionals
Together we can potentially build a more hopeful world for immunocompromised patients
At Chimerix, we’re committed to driving the development of groundbreaking medicines designed to protect immunocompromised patients from potentially deadly viral infections.
Cytomegalovirus (CMV) is a member of the herpesvirus family and remains a significant cause of viral infections in transplant recipients.
Adenovirus, which causes the common cold in people with healthy immune systems, can lead to life-threatening infections in immunocompromised people.
Though smallpox has been officially eradicated, it remains a threat in cases of bio error or as a potential bioterror weapon.